At this spring continuing education event, we will focus on an important topic in infection diagnostics and microbiology: the growing problem of antibiotic resistance and the associated challenges for diagnostics and therapy.

We are pleased to welcome Professor Dr. med. Patrice Nordmann as a speaker for our continuing education academy. He is the head of the National Reference Laboratory for the Early Detection and Monitoring of Emerging Antibiotic Resistance (NARA) at the University of Fribourg.

The lecture will focus on how multidrug-resistant pathogens develop and how they can be detected at an early stage. In addition, we will look at the current resistance situation in Europe and in Switzerland. What developments are emerging and what challenges may we face in the future?

These and other aspects will be addressed in the engaging and informative lecture by Professor Nordmann, who will provide insights into current developments and their significance for medical practice.

This training is intended exclusively for healthcare professionals, as it is specifically tailored to the requirements and expertise of this field.

Details of the training

Date and time: 26 March 2026, starting at 19:00

• 19:00: Arrival and reception
• 19:15: Welcome
• 19:25: Lecture: “Emerging resistance to antibiotics, 2026: myths and reality” Professor Dr. med. Patrice Nordmann, Director of the National Reference Center for Antibiotic Resistance (NARA)
• 21:00: Questions and discussion
• 21:15: Oriental buffet

Location:
Clublokal Sternenfeld
Rebackerweg 4a
4127 Birsfelden

Registration deadline: 
23 March 2026

Speaker:
Professor Dr. med. Patrice Nordmann is Chairman of the Department of Molecular and Medical Microbiology at the Faculty of Medicine of the University of Fribourg and Director and Founder of the National Reference Center for Antibiotic Resistance. As a trained physician in infectious diseases and medical microbiology, he is co-author of more than 810 publications in the fields of antibiotic resistance, biochemistry, genetics, epidemiology, clinical implications, rapid diagnostic tests, and new treatment approaches.

Participation in this event will be awarded SGAIM credits.